Day 1: Thursday, March 2 | Day 2 | Day 3
Tutorial videos now available (Requires RealPlayer)
1:00 – 4:30 pm
Tutorial: the Basic Science of Human Embryonic Stem Cell Research, and some Foundational Legal and Bioethical Issues
Two experts will conduct this tutorial on some of the basic scientific principles and legal and bioethical issues underlying human embryonic stem cell research.
Michael Shelanski – Columbia University 
pdf
Pilar Ossorio ’97 – University of Wisconsin at Madison Law School ~ Visiting at Boalt Hall School of Law, UC Berkeley pdf
Day 1 | Day 2: Friday, March 3 | Day 3
8:00 – 8:45 am
Registration and Continental Breakfast
8:45 – 9:00 am
Welcoming Address
Dean Christopher Edley – Boalt Hall
9:00 – 10:30 am
Getting Intellectual Property Rights Right: What Model Should Be Adopted?
It’s been 25 years since the adoption of Bayh-Dole, which provides the patent ownership and licensing scheme for federally-funded research. California now has the opportunity to evaluate this approach and other models for inventions resulting from state-funded research. What is the most effective means to induce investment in and commercialization of promising therapeutics while still protecting the public interest?
Moderator: Elizabeth A. Howard – Orrick, Herrington & Sutcliffe LLP
Merrill Goozner – Integrity in Science Project Director, Center for Science in the Public Interest pdf
Robert P. Merges – BCLT and Boalt Hall School of Law, UC Berkeley pdf
David Mowery – Haas School of Business, UC Berkeley pdf
Marjorie Shultz ‘ 76 – Boalt Hall School of Law, UC Berkeley
10:30 – 10:45 am
Break
10:45 – 12:00 pm
Consent, Commodification and Control: The Bioethics of Stem Cell Research
Human eggs, cells and tissue are the foundation of stem cell research. How can donors be protected? What is the best way to ensure appropriate donor consent? Should donors have residual control rights over their eggs, tissue and cells? Is there a danger of market considerations overtaking issues of human and personal importance?
Moderator: Susan Nicholson – Ropes & Gray LLP
Lori Andrews – Chicago-Kent College of Law
Sean O’Connor – University of Washington pdf
Radhika Rao – UC Hastings
David Winickoff – College of Natural Resources, UC Berkeley *
12:00 – 2:00 pm
Lunch and Panel Presentation
Keeping Stem Cell Research on Track: Balancing the Interests
What are the roles of the different constituencies — the public, patients, government, researchers, and industry — in decision making? Can these interests be balanced? How can the development of cures proceed and the public interest best be served?
Moderator: David Ewing Duncan – Founder and Editorial Director, BioAgenda
David Gollaher – President & CEO, California Healthcare Institute
Senator Deborah Ortiz – Health & Human Services Committee Chair, California Senate
Ed Penhoet – Independent Citizens’ Oversight Committee and Vice-Chair, California Institute for Regenerative Medicine
Jesse Reynolds – Project Director for Biotechnology Accountability, Center for Genetics and Society
Joan Samuelson ’77 – Parkinson’s Action Network
2:00 – 3:30 pm
How Can the State Recoup Its Investment (Or Should It?)
To finance stem cell research, the state will issue $3 billion in GO bonds. California is already operating with a massive deficit. Should mechanisms be put in place to pay back the State? If so, what form should this take — a royalty stream, an increased tax base? What are the implications for investment and innovation? What are the prospects for reduced costs in public health care? Or should the payback be the advancement of science and human health?
Moderator: John R. Wetherell – Pillsbury Winthrop Shaw Pittman LLP
Richard Gilbert – Department of Economics, UC Berkeley pdf *
Michael D. Goldberg – General Partner, MDV
Perry Israel – Partner, Orrick, Herrington & Sutcliffe LLP pdf
Theodore R. Marmor – School of Management, Yale University
Roger Noll – Stanford Economics Department, Stanford University *
Jean M. Ross – California Budget Project
3:30 – 3:45 pm
Break
3:45 – 5:15 pm
The Implications for Health Care: Learning from What Is and Shaping What Will Be
What can we learn from past large scale health care projects? How do we know when it’s appropriate to conduct clinical trials? Can the ultimate cures and benefits be equitably distributed? Which diseases should be tackled first? What are the implications for affordability of and access to potential cures?
Moderator: Ken Taymor – MBV Law LLP
Jay Bhattacharya – Stanford Center for Health Policy
Bernard Lo – Director of CAPS Ethics Core, UCSF Part 1 | Part 2
Jeff Sheehy – AIDS Research Institute, UCSF
Charis Thompson – Gender Studies and Rhetoric, UC Berkeley pdf
5:30 – 7:00 pm
Reception sponsored by Dewey Ballantine LLP
Day 1 | Day 2 | Day 3: Saturday, March 4
8:00 – 9:00 am
Registration and Continental Breakfast
9:00 – 10:30 am
On the Ownership of Data – Copyright, Public Domain or Open Source?
Just as significant as patent policy is the ownership policy for databases, data, bioinformatics software, and research articles. How can innovation be encouraged in this arena while still protecting the public interest? Which ownership scheme will best advance the science?
Moderator: Robert Sloss – Farella Braun + Martel LLP
Michael Eisen Lawrence Berkeley National Laboratory, UC Berkeley
Rebecca Eisenberg ‘ 79 – University of Michigan Law School
Stephen Maurer – Goldman School of Public Policy, UC Berkeley pdf
Arti Rai – Duke University Law School
10:30 – 10:45 am
Break
10:45 – 12:15 pm
The Comparative Context: National and International Approaches to Stem Cell Policy
Other jurisdictions have faced/are facing these same dilemmas. What can we learn from their successes and failures? Should we do things differently?
Moderator: Sergio Garcia ’86 – Fenwick & West LLP
R. Alta Charo – University of Wisconsin at Madison Law School ~ visiting at Boalt Hall School of Law, UC Berkeley
Mildred K. Cho – Stanford University Center for Biomedical Ethics
Rosario Isasi – Centre de Recherche en Droit Public, Université de Montréal pdf
Christopher Thomas Scott – Stanford Stem Cell Center pdf
12:15 – 2:00 pm
Lunch and Panel Presentation
The Political Process and Stem Cell Research: How did we get here and what can we learn?
Organized and sponsored by the Travers Ethics Program at UC Berkeley
The debate surrounding stem cell research in general, and Prop 71 in particular, raises a number of questions about the role of democratic control in scientific, legal and policy decisions. Should there be democratic control and if so how should that be facilitated? How can we have intelligent public debates about highly technical issues like stem cell research? What have we learned from Prop 71 about the role of democratic debate that might inform future initiatives? Are initiatives, which by definition are structured to appeal to the public, the best model?
Moderator: Robert Price Associate Vice Chancellor for Research and Professor of Political Science, UC Berkeley
Marcy Darnovsky – Center for Genetics and Society
Theodore R. Marmor – School of Management, Yale University
Joanna Weinberg – Institute for Health and Aging, UCSF pdf
* These individuals will contribute an article to the BTLJ Symposium Issue.